Condition: Non-small Cell Lung Cancer · Sponsor: Allist Pharmaceuticals, Inc.
Evaluate the safety and tolerability, drug levels, and clinical activity of JAB-21822 in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors with KRAS p.G12C mutation and a serine/threonine kinase 11 (STK11) co-mutation.
This description comes directly from the study's public registry record.
Shanghai Allist Pharmaceuticals Co., Ltd Shanghai Allist Pharmaceuticals Co., Ltd · 021-80423288 · zhenhua.gong@allist.com.cn
Wang Jie Wang Jie M.D. · 010-87788029 · zlhuxi@163.com
Always discuss trial participation with your own doctor first.
| Research site08 | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Research site09 | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Research site021 | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Research site02 | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Research site01 | Beijing, Beijing Municipality, China | Recruiting |
| Research site013 | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Research site010 | Chongqing, Chongqing Municipality, China | Not Yet Recruiting |
| Research site05 | Xiamen, Fujian, China | Not Yet Recruiting |
| Research site011 | Shenzhen, Guangdong, China | Not Yet Recruiting |
| Research site016 | Nanning, Guangxi, China | Not Yet Recruiting |
| Research site017 | Shijiazhuang, Hebei, China | Not Yet Recruiting |
| Research site018 | Harbin, Heilongjiang, China | Not Yet Recruiting |
+ 9 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05276726